ClinicalTrials.gov record
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
ClinicalTrials.gov ID: NCT02526017
Public ClinicalTrials.gov record NCT02526017. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1a/1b Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
Study identification
- NCT ID
- NCT02526017
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Five Prime Therapeutics, Inc.
- Industry
- Enrollment
- 313 participants
Conditions and interventions
Conditions
Interventions
- Cabiralizumab Biological
- Nivolumab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 7, 2015
- Primary completion
- Nov 17, 2019
- Completion
- Nov 17, 2019
- Last update posted
- Mar 8, 2022
2015 – 2019
United States locations
- U.S. sites
- 39
- U.S. states
- 21
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scottsdale Healthcare Hospitals DBA Honor Health | Scottsdale | Arizona | 85258 | — |
| Moores UC San Diego Cancer Center | La Jolla | California | 92093 | — |
| Norris Comprehensive Cancer Center, University of Southern California | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center | Los Angeles | California | 90048 | — |
| UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Sarcoma Oncology Research Center | Santa Monica | California | 90403 | — |
| UCLA Hematology/Oncology- Santa Monica | Santa Monica | California | 90404 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Indiana University Health Hospital | Indianapolis | Indiana | 46202 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Norton Cancer Institute, Norton Healthcare Pavilion | Louisville | Kentucky | 40202 | — |
| Johns Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21287 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Allina Health, Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Memorial Sloan Kettering | New York | New York | 10065 | — |
| The Christ Hospital | Cincinnati | Ohio | 45219 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Hollings Cancer Center, Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Henry-Joyce Cancer Clinic, Vanderbilt-Ingram Cancer Center, | Nashville | Tennessee | 37232 | — |
| Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center | Dallas | Texas | 75246 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Mischer Neuroscience Associates, The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
| South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02526017, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2022 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02526017 live on ClinicalTrials.gov.